1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Tuberculosis Diagnostics Market
2.3. Global Tuberculosis Diagnostics Market, By Test, 2025 (US$ Million)
2.4. Global Tuberculosis Diagnostics Market, By Geography, 2025 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2025

3. Tuberculosis Diagnostics Market: Competitive Analysis
3.1. Market Positioning of Key Tuberculosis Diagnostics Market Vendors
3.2. Strategies Adopted by Tuberculosis Diagnostics Market Vendors

4. Tuberculosis Diagnostics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Tuberculosis Diagnostics Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape

5. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Radiographic Methods
5.3.2. Laboratory Methods
5.3.2.1. Smear Microscopy
5.3.2.2. Culture Based Test
5.3.3. Nucleic Acid Testing
5.3.4. Phage Assay
5.3.5. Cytokine Detection Test
5.3.6. Detection of Drug Resistance
5.3.7. Mantoux Test

6. North America Tuberculosis Diagnostics Market, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
6.3. Tuberculosis Diagnostics Market: By Region, 2024-2034, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)

7. UK and European Union Tuberculosis Diagnostics Market, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
7.3. Tuberculosis Diagnostics Market: By Region, 2024-2034, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
7.3.1.5. France
7.3.1.5.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)

8. Asia Pacific Tuberculosis Diagnostics Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
8.3. Tuberculosis Diagnostics Market: By Region, 2024-2034, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
8.3.1.3. India
8.3.1.3.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)

9. Latin America Tuberculosis Diagnostics Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
9.3. Tuberculosis Diagnostics Market: By Region, 2024-2034, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)

10. Middle East and Africa Tuberculosis Diagnostics Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
10.3. Tuberculosis Diagnostics Market: By Region, 2024-2034, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Tuberculosis Diagnostics Market: By Test, 2024-2034, USD (Million)

11. Company Profile
11.1. Abbott Laboratories (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
11.2. Alere, Inc.
11.3. Becton Dickinson and Company
11.4. bioMérieux SA
11.5. Cepheid Inc.
11.6. Epistem plc
11.7. F. Hoffman La Roche AG
11.8. Hain Lifescience GmbH
11.9. Hologic Corporation
11.10. Thermo Fisher Scientific, Inc.
11.11. QIAGEN